Trials / Completed
CompletedNCT04820049
F573 Ia Clinical Trial
F573 for Injection Phase Ia Clinical Trial.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Tolerance and PK study of F573
Detailed description
The tolerance and PK study of single dose and multi dose F573.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | F573 | F573 for injection |
| OTHER | Placebo | Water for injection |
Timeline
- Start date
- 2021-02-08
- Primary completion
- 2022-08-02
- Completion
- 2022-11-06
- First posted
- 2021-03-29
- Last updated
- 2022-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04820049. Inclusion in this directory is not an endorsement.